BACKGROUND: There are no evidence-based treatments for severe and enduring anorexia nervosa (SE-AN). This study evaluated the relative efficacy of cognitive behavioral therapy (CBT-AN) and specialist supportive clinical management (SSCM) for adults with SE-AN. METHOD: Sixty-three participants with a diagnosis of AN, who had at least a 7-year illness history, were treated in a multi-site randomized controlled trial (RCT). During 30 out-patient visits spread over 8 months, they received either CBT-AN or SSCM, both modified for SE-AN. Participants were assessed at baseline, end of treatment (EOT), and at 6- and 12-month post-treatment follow-ups. The main outcome measures were quality of life, mood disorder symptoms and social adjustment. Weight, eating disorder (ED) psychopathology, motivation for change and health-care burden were secondary outcomes. RESULTS: Thirty-one participants were randomized to CBT-AN and 32 to SSCM with a retention rate of 85% achieved at the end of the study. At EOT and follow-up, both groups showed significant improvement. There were no differences between treatment groups at EOT. At the 6-month follow-up, CBT-AN participants had higher scores on the Weissman Social Adjustment Scale (WSAS; p = 0.038) and at 12 months they had lower Eating Disorder Examination (EDE) global scores (p = 0.004) and higher readiness for recovery (p = 0.013) compared to SSCM. CONCLUSIONS: Patients with SE-AN can make meaningful improvements with both therapies. Both treatments were acceptable and high retention rates at follow-up were achieved. Between-group differences at follow-up were consistent with the nature of the treatments given.
RCT Entities:
BACKGROUND: There are no evidence-based treatments for severe and enduring anorexia nervosa (SE-AN). This study evaluated the relative efficacy of cognitive behavioral therapy (CBT-AN) and specialist supportive clinical management (SSCM) for adults with SE-AN. METHOD: Sixty-three participants with a diagnosis of AN, who had at least a 7-year illness history, were treated in a multi-site randomized controlled trial (RCT). During 30 out-patient visits spread over 8 months, they received either CBT-AN or SSCM, both modified for SE-AN. Participants were assessed at baseline, end of treatment (EOT), and at 6- and 12-month post-treatment follow-ups. The main outcome measures were quality of life, mood disorder symptoms and social adjustment. Weight, eating disorder (ED) psychopathology, motivation for change and health-care burden were secondary outcomes. RESULTS: Thirty-one participants were randomized to CBT-AN and 32 to SSCM with a retention rate of 85% achieved at the end of the study. At EOT and follow-up, both groups showed significant improvement. There were no differences between treatment groups at EOT. At the 6-month follow-up, CBT-ANparticipants had higher scores on the Weissman Social Adjustment Scale (WSAS; p = 0.038) and at 12 months they had lower Eating Disorder Examination (EDE) global scores (p = 0.004) and higher readiness for recovery (p = 0.013) compared to SSCM. CONCLUSIONS:Patients with SE-AN can make meaningful improvements with both therapies. Both treatments were acceptable and high retention rates at follow-up were achieved. Between-group differences at follow-up were consistent with the nature of the treatments given.
Authors: James Lock; Daniel Le Grange; W Stewart Agras; Kathleen Kara Fitzpatrick; Booil Jo; Erin Accurso; Sarah Forsberg; Kristen Anderson; Kate Arnow; Maya Stainer Journal: Behav Res Ther Date: 2015-08-01
Authors: Jennifer E Wildes; Marsha D Marcus; Yu Cheng; Elizabeth B McCabe; Jill A Gaskill Journal: Int J Eat Disord Date: 2014-01-10 Impact factor: 4.861
Authors: Leslie K Anderson; Erin E Reilly; Laura Berner; Christina E Wierenga; Michelle D Jones; Tiffany A Brown; Walter H Kaye; Anne Cusack Journal: Curr Psychiatry Rep Date: 2017-08 Impact factor: 5.285
Authors: Hope K Boyd; Andrea E Kass; Erin C Accurso; Andrea B Goldschmidt; Jennifer E Wildes; Daniel Le Grange Journal: Int J Eat Disord Date: 2017-04-21 Impact factor: 4.861
Authors: Eunice Y Chen; Kay Segal; Jessica Weissman; Thomas A Zeffiro; Robert Gallop; Marsha M Linehan; Martin Bohus; Thomas R Lynch Journal: Int J Eat Disord Date: 2014-10-27 Impact factor: 4.861
Authors: Kamryn T Eddy; Nassim Tabri; Jennifer J Thomas; Helen B Murray; Aparna Keshaviah; Elizabeth Hastings; Katherine Edkins; Meera Krishna; David B Herzog; Pamela K Keel; Debra L Franko Journal: J Clin Psychiatry Date: 2017-02 Impact factor: 4.384